Market Research Report

Product code

915979

Asia Pacific Metabolomics Market Forecast 2019-2027

Published: November 8, 2019 |

Inkwood Research | 107 Pages | Delivery time: 2-3 business days

Price

Description
Table of Contents
List of Tables

Add to Compare

KEY FINDINGS

The market for metabolomics in the Asia Pacific region is set to witness the highest CAGR of 12.33% during the projected period, 2019-2027. The extensive presence of economically diverse countries like India and China, is one of the many dominant factors driving the growth of the metabolomics market in the region.

MARKET INSIGHTS

The market region of Asia Pacific with regard to the metabolomics market is assessed by taking into consideration the countries of Australia, Japan, South Korea, China, India, and the Rest of Asia Pacific. The metabolomics R&D activities have been registering significant development in countries like South Korea, Japan, and Taiwan. In regions like Japan, the introduction of programs to augment the biological knowledge in metabolomics in the areas of environment and energy, along with a focus on developing precision medicine, is immensely affecting the growth of the metabolomics market in the region. The government initiatives are also aiding the growth of the market in Japan. In countries like China, the medical institutions take center stage when it comes to drug discovery. The drug discovery and development in the region are enhanced thought investments made by both, government and private sectors. The participation of industries in major applications is encouraged by the government. The pharmaceutical industry of the region is undergoing a gradual transformation, which is another factor projected to influence the growth of the metabolomics market in the region.

COMPETITIVE INSIGHTS

Some of the eminent market players have emerged in the market, along with varied innovations in their products. Apical Scientific Sdn Bhd, Thermo Fisher Scientific Inc., Metabolon Inc., Leco Corporation, Bruker Corporation, Perkinelmer, Inc., Shimadzu Corporation, etc. are among the eminent companies of the market.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation cater to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 28109

1. RESEARCH SCOPE

1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

2.1. SOURCES OF DATA

2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA

2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

3.1. MARKET SUMMARY
3.2. KEY FINDINGS

3.2.1. METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES ARE THE FASTEST GROWING PRODUCT & SERVICE
3.2.2. BIOMARKER DISCOVERY IS THE WIDELY USED APPLICATION
3.2.3. CANCER IS THE MOST PREVALENT INDICATION

4. MARKET DYNAMICS

4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS

4.2.1. GROWING INVESTMENTS IN THE METABOLOMICS DOMAIN BY THE PUBLIC AND PRIVATE SECTORS
4.2.2. RISE IN THE DEMAND FOR PERSONALIZED MEDICINES
4.2.3. UPSURGE IN THE INCIDENCES OF CHRONIC DISEASE

4.3. MARKET RESTRAINTS

4.3.1. LACK OF SKILLED PROFESSIONALS IN METABOLOMICS
4.3.2. HIGH COST OF THE INSTRUMENTS

4.4. MARKET OPPORTUNITIES

4.4.1. EMERGING APPLICATION OF METABOLOMICS IN HUMAN NUTRITION
4.4.2. GROWING USAGES IN THE EARLY DETECTION OF CHRONIC DISEASES

4.5. MARKET CHALLENGES

4.5.1. COMPLEX AND DIVERSE NATURE OF THE BIOLOGICAL SAMPLES

5. MARKET BY PRODUCT & SERVICE

5.1. METABOLOMICS INSTRUMENTS

5.1.1. SEPARATION TECHNIQUE
5.1.2. DETECTION TECHNIQUE

5.2. METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES

6. MARKET BY APPLICATION

6.1. BIOMARKER DISCOVERY
6.2. DRUG DISCOVERY
6.3. TOXICOLOGY TESTING
6.4. NUTRIGENOMICS
6.5. FUNCTIONAL GENOMICS
6.6. PERSONALIZED MEDICINE
6.7. OTHER APPLICATION

7. MARKET BY INDICATION

7.1. CANCER
7.2. CARDIOVASCULAR DISORDERS
7.3. NEUROLOGICAL DISORDERS
7.4. INBORN ERRORS OF METABOLISM
7.5. OTHER INDICATION

8. KEY ANALYTICS

8.1. PORTER'S FIVE FORCES MODEL

8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE
8.1.3. BARGAINING POWER OF BUYERS
8.1.4. BARGAINING POWER OF SUPPLIERS
8.1.5. THREAT OF COMPETITIVE RIVALRY

8.2. VALUE CHAIN ANALYSIS
8.3. MARKET TRENDS
8.4. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS

9.1. ASIA PACIFIC

9.1.1. JAPAN
9.1.2. CHINA
9.1.3. AUSTRALIA
9.1.4. INDIA
9.1.5. SOUTH KOREA
9.1.6. REST OF ASIA PACIFIC

10. COMPETITIVE LANDSCAPE

10.1. MARKET POSITION ANALYSIS
10.2. COMPANY PROFILES

10.2.1. AGILENT TECHNOLOGIES, INC.
10.2.2. APICAL SCIENTIFIC SDN BHD
10.2.3. BIOCRATES LIFE SCIENCES AG
10.2.4. BIO-RAD LABORATORIES, INC.
10.2.5. BRUKER CORPORATION
10.2.6. CREATIVE PROTEOMICS
10.2.7. DANAHER CORPORATION (SCIEX)
10.2.8. HUMAN METABOLOME TECHNOLOGIES, INC.
10.2.9. KORE TECHNOLOGY LIMITED
10.2.10. LECO CORPORATION
10.2.11. METABOLON INC.
10.2.12. PERKINELMER, INC.
10.2.13. SHIMADZU CORPORATION
10.2.14. THERMO FISHER SCIENTIFIC INC.
10.2.15. WATERS CORPORATION

LIST OF TABLES

TABLE 1: ASIA PACIFIC METABOLOMICS MARKET, 2019-2027 ($ MILLION)
TABLE 2: ASIA PACIFIC METAGENOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
TABLE 3: ASIA PACIFIC METABOLOMICS INSTRUMENTS MARKET, 2019-2027 ($ MILLION)
TABLE 4: ASIA PACIFIC METABOLOMICS INSTRUMENTS MARKET, BY TYPE, 2019-2027 ($ MILLION)
TABLE 5: ASIA PACIFIC SEPARATION TECHNIQUE MARKET, 2019-2027 ($ MILLION)
TABLE 6: ASIA PACIFIC DETECTION TECHNIQUE MARKET, 2019-2027 ($ MILLION)
TABLE 7: ASIA PACIFIC METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES MARKET, 2019-2027 ($ MILLION)
TABLE 8: ASIA PACIFIC METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
TABLE 9: ASIA PACIFIC BIOMARKER DISCOVERY MARKET, 2019-2027 ($ MILLION)
TABLE 10: ASIA PACIFIC DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
TABLE 11: ASIA PACIFIC TOXICOLOGY TESTING MARKET, 2019-2027 ($ MILLION)
TABLE 12: ASIA PACIFIC NUTRIGENOMICS MARKET, 2019-2027 ($ MILLION)
TABLE 13: ASIA PACIFIC FUNCTIONAL GENOMICS MARKET, 2019-2027 ($ MILLION)
TABLE 14: ASIA PACIFIC PERSONALIZED MEDICINE MARKET, 2019-2027 ($ MILLION)
TABLE 15: ASIA PACIFIC OTHER APPLICATION MARKET, 2019-2027 ($ MILLION)
TABLE 16: ASIA PACIFIC METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
TABLE 17: ASIA PACIFIC CANCER MARKET, 2019-2027 ($ MILLION)
TABLE 18: ASIA PACIFIC CARDIOVASCULAR DISORDERS MARKET, 2019-2027 ($ MILLION)
TABLE 19: ASIA PACIFIC NEUROLOGICAL DISORDERS MARKET, 2019-2027 ($ MILLION)
TABLE 20: ASIA PACIFIC INBORN ERRORS OF METABOLISM MARKET, 2019-2027 ($ MILLION)
TABLE 21: ASIA PACIFIC OTHER INDICATION MARKET, 2019-2027 ($ MILLION)
TABLE 22: ASIA PACIFIC METABOLOMIC SMARKET, BY COUNTRY, 2019-2027 ($ MILLION)
TABLE 23: JAPAN METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
TABLE 24: JAPAN METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
TABLE 25: JAPAN METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
TABLE 26: CHINA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
TABLE 27: CHINA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
TABLE 28: CHINA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
TABLE 29: AUSTRALIA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
TABLE 30: AUSTRALIA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
TABLE 31: AUSTRALIA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
TABLE 32: INDIA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
TABLE 33: INDIA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
TABLE 34: INDIA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
TABLE 35: SOUTH KOREA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)
TABLE 36: SOUTH KOREA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
TABLE 37: SOUTH KOREA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)
TABLE 38: METABOLOMICS COMPANY MARKET POSITION ANALYSIS, 2018

LIST OF FIGURES

FIGURE 1: ASIA PACIFIC METABOLOMICS MARKET, 2019-2027 ($ MILLION)
FIGURE 2: ASIA PACIFIC METAGENOMICS MARKET, BY METABOLOMICS INSTRUMENTS, 2019-2027 ($ MILLION)
FIGURE 3: ASIA PACIFIC METABOLOMICS INSTRUMENTS MARKET, BY SEPARATION TECHNIQUE, 2019-2027 ($ MILLION)
FIGURE 4: ASIA PACIFIC METABOLOMICS INSTRUMENTS MARKET, BY DETECTION TECHNIQUE, 2019-2027 ($ MILLION)
FIGURE 5: ASIA PACIFIC METAGENOMICS MARKET, BY METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES, 2019-2027 ($ MILLION)
FIGURE 6: ASIA PACIFIC METABOLOMICS MARKET, BY BIOMARKER DISCOVERY, 2019-2027 ($ MILLION)
FIGURE 7: ASIA PACIFIC METABOLOMICS MARKET, BY DRUG DISCOVERY, 2019-2027 ($ MILLION)
FIGURE 8: ASIA PACIFIC METABOLOMICS MARKET, BY TOXICOLOGY TESTING, 2019-2027 ($ MILLION)
FIGURE 9: ASIA PACIFIC METABOLOMICS MARKET, BY NUTRIGENOMICS, 2019-2027 ($ MILLION)
FIGURE 10: ASIA PACIFIC METABOLOMICS MARKET, BY FUNCTIONAL GENOMICS, 2019-2027 ($ MILLION)
FIGURE 11: ASIA PACIFIC METABOLOMICS MARKET, BY PERSONALIZED MEDICINE, 2019-2027 ($ MILLION)
FIGURE 12: ASIA PACIFIC METABOLOMICS MARKET, BY OTHER APPLICATION, 2019-2027 ($ MILLION)
FIGURE 13: ASIA PACIFIC METABOLOMICS MARKET, BY CANCER, 2019-2027 ($ MILLION)
FIGURE 14: ASIA PACIFIC METABOLOMICS MARKET, BY CARDIOVASCULAR DISORDERS, 2019-2027 ($ MILLION)
FIGURE 15: ASIA PACIFIC METABOLOMICS MARKET, BY NEUROLOGICAL DISORDERS, 2019-2027 ($ MILLION)
FIGURE 16: ASIA PACIFIC METABOLOMICS MARKET, BY INBORN ERRORS OF METABOLISM, 2019-2027 ($ MILLION)
FIGURE 17: ASIA PACIFIC METABOLOMICS MARKET, BY OTHER INDICATION, 2019-2027 ($ MILLION)
FIGURE 18: PORTER'S FIVE FORCE MODEL
FIGURE 19: JAPAN METABOLOMICS MARKET, 2019-2027 ($ MILLION)
FIGURE 20: CHINA METABOLOMICS MARKET, 2019-2027 ($ MILLION)
FIGURE 21: AUSTRALIA METABOLOMICS MARKET, 2019-2027 ($ MILLION)
FIGURE 22: INDIA METABOLOMICS MARKET, 2019-2027 ($ MILLION)
FIGURE 23: SOUTH KOREA METABOLOMICS MARKET, 2019-2027 ($ MILLION)
FIGURE 24: REST OF ASIA PACIFIC METABOLOMICS MARKET, 2019-2027 ($ MILLION)